Singapore Offers New Hope to Cancer Patients
Singapore is flexing muscles in cancer research seemingly all out of proportion to its size. The country has carved a niche for itself by focusing research on select cancers, as well as offering patients of advanced cancer the possibility of targeted therapies
A new clinical trial is now underway and outcomes are expected to have far-reaching implications for both doctors and their patients.
The trial is considered groundbreaking for several reasons, not least because it uses the patient’s own immune system to fight the cancer. Helmed by Dr Toh Han Chong, Head of Department of Medical Oncology at the National Cancer Centre in Singapore (NCCS), the study currently involves 38 patients. The NCCS is a multi-disciplinary centre that offers one-stop cancer diagnosis and treatment, and carries out cutting-edge cancer research.
Related posts:
- Henry Ford Hospital Offers Free Prostate Cancer Screenings
- Color of Hope: Because All Women Are Worth It
- Colon Cancer Cured After Four Months of New Treatment
- Treadmill Desks Good for Lowering Breast Cancer Risks
